title: Advancing treatment options for influenza: challenges with the human influenza challenge.
authors.affiliation: Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
authors.forename: Alicia M
authors.initials: AM
authors.lastname: Fry
authors.affiliation: Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
authors.forename: Weimin
authors.initials: W
authors.lastname: Zhong
authors.affiliation: Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
authors.forename: Larisa V
authors.initials: LV
authors.lastname: Gubareva
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D053122:Influenza A Virus, H3N2 Subtype / Q000276:immunology*; D007251:Influenza, Human / Q000188:drug therapy*; D008297:Male; D053139:Oseltamivir / Q000008:administration & dosage*
chemical_list: D000911:Antibodies, Monoclonal; D007155:Immunologic Factors; D053139:Oseltamivir